Drug-related problems among community-dwelling older adults in mainland China
- 209 Downloads
Background Little is known about the extent of drug-related problems (DRPs) in community-dwelling older adult patients with chronic diseases in mainland China. Setting A medication therapy review service at a community health center in Chongqing, China. Objective To identify and categorize DRPs along with pharmacists’ recommendations in addressing the DRPs identified. Method The study was conducted between May 2015 and July 2016. A total of 102 community-dwelling older adults were included. MTR was carried out by clinical pharmacists. DRPs and pharmacotherapy recommendations were recorded and analyzed. Main outcome measure The number of drug-related problems and main problem categories. Results The average age of patients was 69.4 years. Patients took an average of 6.3 medications. A total of 489 DRPs were identified (mean of 4.8 per patient). The most common category was under-treated (27.8%) followed by over- or under-dose (18.8%) and monitoring (17.8%). The number of medications taken was the significant associated factor for DRPs. Pharmacists made 526 recommendations to address the DRPs (mean of 1.1 recommendations per DRP). Primary care providers accepted 68.1% of these recommendations, and implemented 60.9% of them. Conclusion The prevalence of DRPs among studied patient population was high. Pharmacists may play a vital role in addressing the DRPs and optimize pharmacotherapy through MTR service located in community health centers.
KeywordsChina Community-dwelling older adults Drug-related problems Medication therapy review Pharmacists
We would like to thank Ms. Ling Luo, Ms. Yuying Luo, Ms. Li Lin and other nurses/pharmacists for participants’ enrollment and data collection. We also thank Dr. Jia Yang, Dr. Leju Chen and other physicians for referring their patients to our study.
This project was funded by the Chongqing Science & Technology Commission, Grant Number: cstc2015shmszx0592 and Natural Science Foundation of China, Grant Number: 81603330.
Conflicts of interest
All the authors declare that they have no conflict of interest.
- 1.Xiao N, Long Q, Tang X, Tang S. A community-based approach to non-communicable chronic disease management within a context of advancing universal health coverage in China: progress and challenges. BMC Public Health. 2014;14(2):1.Google Scholar
- 7.Pharmaceutical Care Network Europe (PCNE). Classification for Drug related problems V5.01. http://www.pcne.org/dokumenter/DRP/PCNE%20classification%20V5.01.pdf. Accessed 19 June 2016.
- 10.WHO Collaborating Centre for Drug Statistics Methodology. The anatomical therapeutic chemical (ATC) classification system. http://www.whocc.no/atc/structure_and_principles/. Accessed 19 June 2016.
- 13.Gheewala PA, Peterson GM, Curtain CM, Nishtala PS, Hannan PJ, Castelino RL. Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilities. Drugs Aging. 2014;31(11):825–35.CrossRefPubMedGoogle Scholar
- 25.Hsu S, Ton VK, Dominique Ashen M, Martin SS, Gluckman TJ, Kohli P, et al. A clinician’s guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative. Clin Cardiol. 2013;36(7):383–93.CrossRefPubMedGoogle Scholar